Check-Cap Ltd. (NASDAQ:CHEK – Get Rating) was the recipient of a significant decline in short interest during the month of May. As of May 31st, there was short interest totalling 14,500 shares, a decline of 71.5% from the May 15th total of 50,900 shares. Currently, 0.3% of the shares of the company are short sold. […]
Check-Cap Ltd. (NASDAQ:CHEK – Get Rating) saw a significant increase in short interest in May. As of May 31st, there was short interest totalling 2,160,000 shares, an increase of 58.8% from the May 15th total of 1,360,000 shares. Based on an average daily trading volume, of 695,700 shares, the short-interest ratio is currently 3.1 days. […]
Check-Cap (NASDAQ:CHEK – Get Rating) posted its earnings results on Wednesday. The medical research company reported ($0.06) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.01), MarketWatch Earnings reports. Check-Cap stock opened at $0.36 on Thursday. The company has a market capitalization of $35.08 million, a P/E ratio of -1.73 […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Zacks Investment Research downgraded shares of Check-Cap (NASDAQ:CHEK – Get Rating) from a buy rating to a hold rating in a research note released on Thursday, Zacks.com reports. According to Zacks, “Check Cap Ltd. is a medical diagnostics company. The company is engaged in the development of an ingestible imaging capsule for the screening of […]